172
Participants
Start Date
March 31, 2012
Primary Completion Date
May 15, 2021
Study Completion Date
May 15, 2021
Vitamin D3
Patients will be assigned to low dose (600 IU/day) versus high-dose (5000 IU/day) of vitamin D3 as an add-on therapy to glatiramer acetate (Copaxone).
Columbia University, New York
Dignity Health Medical Foundation, Carmichael
University of California, San Francisco, San Francisco
Stanford University, Stanford
Yale University, New Haven
Anne Arundel Health System Research Institute, Annapolis
Johns Hopkins University School of Medicine, Baltimore
University of Massachusetts, Worcester
Washington University St. Louis, St Louis
Mount Sinai School of Medicine, New York
University of Rochester, Rochester
Cleveland Clinic, Cleveland
Oregon Health Sciences University, Portland
University of Pennsylvania, Philadelphia
University of Virginia, Charlottesville
Swedish Medical Center, Seattle
Collaborators (1)
Oregon Health and Science University
OTHER
University of California, San Francisco
OTHER
Washington University School of Medicine
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
University of Pennsylvania
OTHER
Yale University
OTHER
The Cleveland Clinic
OTHER
University of Rochester
OTHER
Stanford University
OTHER
University of Virginia
OTHER
Swedish Medical Center
OTHER
Anne Arundel Health System Research Institute
OTHER
Columbia University
OTHER
University of Massachusetts, Worcester
OTHER
Dignity Health
OTHER
Johns Hopkins University
OTHER